Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality-Reference-Cited by-同舟云学术

Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality

Published:2020 Issue:1 Volume:15 Page:
ISSN:2211-8179
Container-title:Global Heart
language:en
Short-container-title:

Author:

Zaidel Ezequiel J.,Leng Xinyi,Adeoye Abiodun Moshood,Hakim Ferdous,Karmacharya Biraj,Katbeh Asim,Neubeck Lis,Partridge Stephanie,Perel Pablo,Huffman Mark D.,Cesare Mariachiara Di

Publisher

Ubiquity Press, Ltd.

Subject

Cardiology and Cardiovascular Medicine,Community and Home Care,Epidemiology

Reference27 articles.

1. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation;Eur Heart J,2018

2. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials;Lancet,2014

3. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS;European Journal of Cardio-Thoracic Surgery,2016

4. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons;Circulation,2019

5. Modelling projections for the risks related with atrial fibrillation in East Asia: A focus on ischaemic stroke and death;EP Europace,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Budget Impact Analysis of Adopting Direct Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation Patients in Malawi;Value in Health Regional Issues;2023-09

2. Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?: a review article;The Egyptian Heart Journal;2023-08-28

3. Temporal trends in admissions for atrial fibrillation and severe bleeding in England: an 18-year longitudinal analysis;Scandinavian Cardiovascular Journal;2022-12-15

4. Predictores de uso de anticoagulantes orales directos en tromboembolia pulmonar aguda;Archivos de Cardiología de México;2022-11-23

5. Oral Anticoagulation use in Non-valvular Atrial Fibrillation Patients in Rural Setting;American Journal of Medicine Open;2022-10